{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:11:10Z","timestamp":1789740670189,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ando.2026.102547","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:25:25Z","timestamp":1774682725000},"page":"102547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Facts and news about growth hormone replacement therapy in adults"],"prefix":"10.1016","volume":"87","author":[{"given":"Thierry","family":"Brue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Aouchiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Sahakian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cilia","family":"Piazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Albarel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Morange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Vermalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cuny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Castinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ando.2026.102547_bib0180","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"10444","key":"10.1016\/j.ando.2026.102547_bib0185","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/S0140-6736(24)00342-8","article-title":"Hypopituitarism","volume":"403","author":"Fleseriu","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ando.2026.102547_bib0235","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ando.2024.03.001","article-title":"Position statement on the diagnosis and management of congenital pituitary deficiency in adults: the French National Diagnosis and Treatment Protocol (NDTP)","volume":"85","author":"Castets","year":"2024","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2026.102547_bib351","first-page":"dgaf680","article-title":"Efficacy and Safety of Once-Weekly Lonapegsomatropin in adults with Growth Hormone Deficiency: foresiGHt trial results","volume":"20","author":"Biller","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2026.102547_bib0195","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1530\/EJE-11-1028","article-title":"Overall and cause-specific mortality in GH-deficient adults on GH replacement","volume":"166","author":"Gaillard","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ando.2026.102547_bib0200","doi-asserted-by":"crossref","first-page":"101835","DOI":"10.1016\/j.beem.2023.101835","article-title":"Meta-analysis of mortality in adults with growth hormone deficiency: does growth hormone replacement therapy really improve mortality rates?","volume":"37","author":"van Bunderen","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ando.2026.102547_bib0205","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11102-025-01500-9","article-title":"Prevalence and risk of complications in untreated patients with adult growth hormone deficiency","volume":"28","author":"Fukuoka","year":"2025","journal-title":"Pituitary"},{"issue":"11","key":"10.1016\/j.ando.2026.102547_bib0210","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4158\/GL-2019-0405","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care","volume":"25","author":"Yuen","year":"2019","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.ando.2026.102547_bib0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-07-0013","article-title":"Mortality and GH deficiency: a nationwide study","volume":"157","author":"Stochholm","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.ando.2026.102547_bib0215","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1210\/jc.2003-030346","article-title":"Growth hormone (GH) replacement therapy in adult-onset GH deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial","volume":"89","author":"Hoffman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ando.2026.102547_bib0220","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/EJE-12-1083","article-title":"Fifteen years of GH replacement improves body composition and cardiovascular risk factors","volume":"168","author":"Elbornsson","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ando.2026.102547_bib0225","doi-asserted-by":"crossref","first-page":"101821","DOI":"10.1016\/j.beem.2023.101821","article-title":"Dyslipidaemia and growth hormone deficiency\u00a0\u2013\u00a0a comprehensive review","volume":"37","author":"Hepprich","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2026.102547_bib0230","doi-asserted-by":"crossref","first-page":"910575","DOI":"10.3389\/fendo.2022.910575","article-title":"MRI assessment of cardiac function and morphology in adult patients with growth hormone deficiency: a systematic review and meta-analysis","volume":"13","author":"Bioletto","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"10.1016\/j.ando.2026.102547_bib0240","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2007-0036","article-title":"Growth hormone, insulin-like growth factors, and the skeleton","volume":"29","author":"Giustina","year":"2008","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.ando.2026.102547_bib0245","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11102-024-01464-2","article-title":"Growth hormone and bone: a basic perspective","volume":"27","author":"Bolamperti","year":"2024","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.ando.2026.102547_bib0250","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1359\/jbmr.2001.16.2.398","article-title":"Pharmacia & Upjohn International Metabolic Database. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density","volume":"16","author":"W\u00fcster","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.ando.2026.102547_bib0255","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11102-016-0716-3","article-title":"Fractures in pituitary adenoma patients from the Dutch National Registry of growth hormone treatment in adults","volume":"19","author":"van Varsseveld","year":"2016","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.ando.2026.102547_bib0260","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1210\/clinem\/dgab874","article-title":"State of the art of patient-reported outcomes in acromegaly or GH deficiency: a systematic review and meta-analysis","volume":"107","author":"van der Meulen","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ando.2026.102547_bib0265","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11102-020-01079-3","article-title":"Effect of long-term growth hormone replacement on glucose metabolism in adults with growth hormone deficiency: a systematic review and meta-analysis","volume":"24","author":"Zhou","year":"2021","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.ando.2026.102547_bib0270","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1530\/EC-18-0096","article-title":"The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis","volume":"7","author":"Verhelst","year":"2018","journal-title":"Endocr Connect"},{"issue":"3","key":"10.1016\/j.ando.2026.102547_bib0275","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11102-025-01526-z","article-title":"Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society","volume":"28","author":"Arlien-S\u00f8borg","year":"2025","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.ando.2026.102547_bib0280","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1007\/s12325-025-03188-6","article-title":"Prevalence, treatment patterns, and characteristics of US adults with confirmed or at risk for growth hormone deficiency","volume":"42","author":"Hoffman","year":"2025","journal-title":"Adv Ther"},{"key":"10.1016\/j.ando.2026.102547_bib0285","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000539940","article-title":"Replacement therapy in adults with GHD: how to treat and monitor","volume":"55","author":"Cuboni","year":"2024","journal-title":"Front Horm Res"},{"issue":"3","key":"10.1016\/j.ando.2026.102547_bib0295","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/cen.15000","article-title":"IGF-1 as screening tool for acromegaly and adult-onset growth hormone deficiency in the Netherlands","volume":"100","author":"Postma","year":"2024","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.ando.2026.102547_bib0290","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1210\/jc.2013-1157","article-title":"Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency","volume":"98","author":"Garcia","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ando.2026.102547_bib0300","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1210\/jc.2018-00665","article-title":"Macimorelin as a diagnostic test for adult GH deficiency","volume":"103","author":"Garcia","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ando.2026.102547_bib0305","doi-asserted-by":"crossref","first-page":"e4238","DOI":"10.1210\/clinem\/dgac307","article-title":"Is GH replacement for adult GH deficiency safe?","volume":"107","author":"Melmed","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ando.2026.102547_bib0310","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1210\/clinem\/dgac199","article-title":"Long-term safety of growth hormone in adults with growth hormone deficiency: overview of 15,809 GH-treated patients","volume":"107","author":"Johannsson","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ando.2026.102547_bib0315","doi-asserted-by":"crossref","first-page":"e2121","DOI":"10.1210\/clinem\/dgz149","article-title":"Long-acting growth hormone preparations\u00a0\u2013\u00a0current status and future considerations","volume":"105","author":"Miller","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ando.2026.102547_bib0320","doi-asserted-by":"crossref","first-page":"101788","DOI":"10.1016\/j.beem.2023.101788","article-title":"Comparing treatment with daily and long-acting growth hormone formulations in adults with growth hormone deficiency: challenging issues, benefits, and risks","volume":"37","author":"H\u00f6ybye","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ando.2026.102547_bib0325","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-17-1073","article-title":"Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial","volume":"178","author":"Johannsson","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ando.2026.102547_bib0330","doi-asserted-by":"crossref","first-page":"e1358","DOI":"10.1210\/clinem\/dgaa049","article-title":"Once-weekly somapacitan is effective and well tolerated in adults with GH deficiency: a randomized phase 3 trial","volume":"105","author":"Johannsson","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ando.2026.102547_bib0335","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11102-022-01283-3","article-title":"Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency","volume":"26","author":"Takahashi","year":"2023","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.ando.2026.102547_bib0340","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s12020-024-03834-z","article-title":"Efficacy, safety, and patient satisfaction of Norditropin and Sogroya in patients with growth hormone deficiency: a systematic review and meta-analysis of randomized controlled trials","volume":"85","author":"Altobaishat","year":"2024","journal-title":"Endocrine"},{"issue":"10","key":"10.1016\/j.ando.2026.102547_bib0345","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.eprac.2024.07.003","article-title":"Utilizing somapacitan, a long-acting growth hormone formulation, for the treatment of adult growth hormone deficiency: a guide for clinicians","volume":"30","author":"Yuen","year":"2024","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ando.2026.102547_bib0350","doi-asserted-by":"crossref","first-page":"637209","DOI":"10.3389\/fendo.2021.637209","article-title":"Usefulness and potential pitfalls of long-acting growth hormone analogs","volume":"12","author":"Yuen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426626000685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426626000685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:47:02Z","timestamp":1789739222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426626000685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0003426626000685"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2026.102547","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Facts and news about growth hormone replacement therapy in adults","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2026.102547","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102547"}}